
Huihe Healthcare
汇禾医疗
Huihe Healthcare
Biotech/Healthcare
Since entering the structural heart disease field in 2018, Huihe Medical's first product, K-Clip™ (a transcatheter tricuspid annuloplasty system), has successfully completed its first-in-human humanitarian clinical trial and entered the confirmatory multicenter clinical trial stage. As it continues…
Latest round: Series C (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.